Skip to main content

Advertisement

Table 1 Study procedures

From: Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)

Procedure Baseline Days 1 – 7 Days 8–13 Day 14 Day 30 (end of study)
Clinical evaluation  
Informed consent     
Randomisation     
ECG   
Study drug given   
Full blood count   
Creatinine, electrolytes, eGFR   
Troponin   
hsCRP  
Liver function tests    
IL-6, vWF  
Post discharge follow up visit    
Samples for DNA & RNA    
Cardiac magnetic resonance scan (1)    
ST segment monitoring (2)     
Forearm endothelial study (3)